2 results
Approved WMOCompleted
The primary objective of this trial is to recommend a dose of Lapatinib in combination with Gemcitabine, Cisplatin and possibly Paclitaxel. In order to achieve this, the study will first determine the maximum tolerated dose (MTD) based on the…
Approved WMOCompleted
The overall objective of this study is to evaluate the efficacy and safety of neoGAA in treatment-naïve patients with LOPD as compared to alglucosidase alfa, when this is administered biweekly for a period of 49 weeks. Also, there is an open-label…